A study conducted by experts from Cincinnati University has found that people with dark skin are more likely to die from skin cancer than those with fairer skin. But the disease is less common among dark skin people, although it is often diagnosed later leading to more deaths....

HealthDay - THURSDAY, July 27 (HealthDay News) -- Breast cancer patients with breast implants have the option of breast conservation, rather than full mastectomy, a new study finds.

HealthDay - THURSDAY, July 27 (HealthDay News) -- Breast cancer patients with breast implants have the option of breast conservation, rather than full mastectomy, a new study finds.

Reuters - A program specifically designed to educate Chinese people living in the US about screening for colorectal cancer increased rates of testing significantly, new research shows.

AP - Growing scientific evidence suggests the most widespread industrial contaminant in drinking water — a solvent used in adhesives, paint and spot removers — can cause cancer in people.

AP - A jury awarded $10.4 million to the widow of a former shipyard worker who died of lung cancer after four years of working with materials that contained asbestos.

The World Health Organization says up to 60,000 people a year die from too much exposure to the sun, primarily from skin cancer. Malignant melanomas account for 48,000 deaths each year, while 12,000 people die from other kinds of skin cancer....

Clinical advice for the breast cancer drug Herceptin was questioned by a local health group. They cited vague information regarding patient treatment, cost effectiveness and potential risks.

Johns Hopkins University experts believe they've discovered the key to why testicular cancer has a high survival rate as compared to other types. Testicular cancer cells have been found to be sensitive to heat therapy that may make them more treatable even when they have spread to other organs....

Reuters - As many as 60,000 people a year die from too much sun, mostly from malignant skin cancer, the World Health Organization reported on Wednesday.

One of NASCAR's bests from its past received some disheartening news. Former NASCAR champion, began treatments after being diagnosed with lung cancer on Wednesday.

Reuters - Women may often lack information about breast cancer on their father's side of the family, a problem that could cloud their view of their own risk, new research suggests.

HealthDay - TUESDAY, July 25 (HealthDay News) -- A combination of chemotherapy plus radiation treatment soon after surgery may significantly improve survival for patients with deadly pancreatic cancer, researchers report.

AP - A judge ruled Tuesday that a 16-year-old cancer patient who has refused conventional medical treatment does not have to report to a hospital as previously ordered and scheduled a trial to settle the dispute.

AP - Older women who take hormone pills that combine estrogen and testosterone more than double their risk of breast cancer, according to a study of more than 70,000 nurses.

AP - A new but unproven theory says body heat might explain Lance Armstrong's astounding victory over testicular cancer. The theory — disputed by Armstrong's doctor — refers to the unusually high cure rate for testicular cancer, even when it has spread to other parts of the body.

U.S. researchers stated on Monday that Tamoxifen, the pill that prevents breast cancer in high-risk women, does not appear in the long run to save many lives. Researchers report that women at the highest risk of breast cancer do appear to be living longer if they take Tamoxifen....

AP - A new but unproven theory says body heat might explain Lance Armstrong's astounding victory over testicular cancer.

HealthDay - TUESDAY, July 25 (HealthDay News) -- A combination of chemotherapy plus radiation treatment soon after surgery may significantly improve survival for patients with deadly pancreatic cancer, researchers report.

The Food and Drug Administration has expanded approval of the drug Oncaspar for the treatment of newly diagnosed acute lymphoblastic leukemia (ALL). The FDA had previously approved Oncaspar in 1994, but only for ALL patients who were allergic to the cancer drug L-asparaginase....